Three diabetic cases of acute dizziness due to initial administration of voglibose

Internal Medicine

Volumn 37, Issue 9, 1998, Pages 753-756

  Bando, Yukihiro ^a   Ushiogi, Yasuyuki ^a   Toya, Daisyu ^a   Tanaka, Nobuyoshi ^a   Fujisawa, Masakiyo ^a  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

Author keywords

Adverse effect; Non insulin dependent diabetes mellitus (NIDDM); glucosidase inhibitor

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIBIOTIC AGENT; DOCARPAMINE; ENALAPRIL; FUROSEMIDE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; LEVOTHYROXINE SODIUM; OXYBUTYNIN; TICLOPIDINE; TOLBUTAMIDE; VINPOCETINE; VOGLIBOSE; WARFARIN;

AGED; AREFLEXIA; ARTICLE; BRAIN ISCHEMIA; BRONCHOPNEUMONIA; CASE REPORT; CONGESTIVE HEART FAILURE; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PROSTATE HYPERTROPHY; PROTEINURIA; VERTIGO; VOMITING;

EID: 0031735164     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.753     Document Type: Article

References (14)

1. Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-121, 1985.
2. Stout RW, Insulin and atheroma; 20-yr perspective. Diabetes Care 13: 631-654, 1990 (see comments).
3. Sobajima H, Kato K, Sano H, et al. The effect and gastro-iniestinal symptoms of acarbose in non-insulin-dependent diabetes mellitus (In Japanese). J Practical Diabetes 12: 399-404, 1995.
4. Baba S. Alpha-glucosidase inhibitor. in: Novel Development in Pharmacological Therapy of Diabetes, Baba S. Eds. Churchill Livingstone, Japan, 1994: 53-54 (in Japanese).
5. Ohno T. Investigation of gastrointestinal adverse effects by alpha-glucosidase inhibitor, especially the development of ileus. J New Remedies & Clinics 44: 1114-1116, 1995 (in Japanese).
6. Carrascosa M, Pascual F, Aresti S. Acarbose-induced acute severe hepatotoxicity. Lancet 349: 698-699, 1997 (letter).
7. Masumoto T, Ishikawa M, Yamauchi Y, et al. Drug-induced hepatitis with severe cholestasis due to voglibose. Intern Hepatol Commun 5: 289-296, 1996.
8. Fukuda M. Clinical arrangement of classification of diabetic retinopathy. Tohoku J Exp Med 141 Suppl: 331-335, 1983.
9. Yamane K. Drug-induced dizziness. J Therap 79: 835-843, 1997 (in Japanese).
10. Drug Information of Voglibose for pharmacsists (Takeda Chemical Industries, Ltd.), Osaka, 1994: 35.
11. 14C-acarbose to rats, dogs and man. Arzneim Forsch 39: 1254-1260, 1989.
12. Hiraga K. Pharmacokinetics of AO-128 and its influences on carbohydrate metabolism: A study in healthy volunteers. Kiso to Rinsyo 26: 283-294, 1992 (in Japanese).
13. Fukase N, Takahashi H, Manaka H, et al. Effects of AO-128, alpha-glucosidase inhibitor on secretion of gastric inhibitory polypeptide and truncatedglucagon-like peptide-1. Kiso to Rinsyo 25: 103-109, 1991 (in Japanese).
14. Azuma J, Harada S, Awada O, et al. Pharmacokinetics of BAYg 5421 (Acarbose) and its influences on carbohydrate metabolism - a study in healthy volunteers. Jpn J Med Pharm Sci 22: 365-381, 1989 (in Japanese).